The page is the record's research on the issuer — no analyst, no rating, no view. # Edesa Biotech, Inc. (NASDAQ: EDSA) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Edesa Biotech, Inc., listed on NASDAQ under ticker EDSA, ISIN US27966L3069. The LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-A1). The security type is Corporate, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is British Columbia, Canada. The segment is not on the record. The listing status is listed, not halted. ## The disclosure read The record holds 74 filings across 41 filing days in the window 2025-11-08 to 2026-11-08. The filings comprise 30 directors' dealings, 20 regulatory filings, 8 results, 6 corporate news, 5 prospectuses, 3 director changes and 2 AGM/EGM filings. The median gap between filing days is 6.0 days, the same as the exchange median of 6.0 days and the sector median of 6.0 days. The latest filing is dated 2026-11-05 and is of type directors' dealings, 3 days before the record date. The exchange median latency is 5.0 days and the sector median latency is 4.0 days. The exchange median filings in the window is 52 and the sector median is 63.0. ## Auditor The auditor of record is MNP LLP, located in Toronto, Canada. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change events. The domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). The segment move is not on the record (the exchanges' tier transfers are not EDGAR filings). The halt flag reads listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage The issuer's investor-relations page names four research houses: Brookline Capital Markets, H.C. Wainwright, Lucid Capital Markets and Zacks Small-Cap Research. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The vintage is sealed. The issuer years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 9 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001540159.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/EDSA (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1540159/000117184325007914/edsa20250930_10k.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://www.edesabiotech.com/investors/analyst-coverage/ (coverage) - https://mcp.us-cm-kg.ai/record/NASDAQ/EDSA (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/EDSA · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp